Thank you, Madam Chair.
Thank you for all the testimony. It has certainly been very interesting.
Felicia, you mentioned that here we are in ALS Awareness Month and there doesn't seem to be that much focus on ALS. Just as a silver lining, we have our annual walk in Barrie this Saturday, and we're expecting a huge turnout.
The last time I met you was with Derek Walton, whom we call Braveheart in Barrie. He is in a wheelchair but still manages to skydive to raise money for ALS and the work that's being done at Sunnybrook. Our community certainly embraced him, and there has been tremendous exposure and awareness for ALS, I believe, in Barrie, and I'm sure in lots of small towns across Canada there are similar people like Derek who are raising awareness. I can only hope that is going to continue to grow.
I want to ask a few questions with regard to opportunities that we may not be engaging. It has been clear what the need is in terms of care giving, and I appreciate how that was referenced. That is certainly good advice that we should put in our report. But concerning research and clinical trials, what are we missing the boat on by having, as you mentioned, a very low amount? What clinical research, what research, are we not doing?
Alex or Denise, is there any light you can shed for the committee? If there were greater investments in research, what would we be doing right now?